SLS stock · SLV stock · Lician Pro · $19.99/mo or $149/yr
SLS vs SLV
Sellas Life Sciences Group Inc (SLS) versus iShares Silver Trust (SLV) — a side-by-side from cached financials, not a winner call.
Sellas Life Sciences Group Inc (SLS) is a biotechnology company listed on US.
iShares Silver Trust (SLV) common stock listed on NYSE ARCA.
Latest reported SLS revenue for 2023-12-31 was $0. Net income was -$37.3M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. SLS currently screens at market cap $1.62B.
SLV does not have a complete income-statement cache yet.
SLS currently screens at market cap $1.62B.
Not investment advice. Open the SLS and SLV stock pages for the full models.
Basic comparison
Price, market cap, and trailing P/E stay on this page.
| Metric | SLS | SLV |
|---|---|---|
| Price | $9.98 | $51.51 |
| Market cap | $1.62B | — |
| Trailing P/E | — | — |
Deeper peer metrics
Net income and multi-year revenue growth are the peek. More peer metrics open below. This block stops at the labels.
| Metric | SLS | SLV |
|---|---|---|
| Net income | Pro | Pro |
| Revenue growth | Pro | Pro |
More peer metrics
Operating margin, EPS, free cash flow, and gross margin are on Pro.
SLS vs SLV comparison FAQ
What is SLS's market cap?
Sellas Life Sciences Group Inc (SLS) currently screens at market cap $1.62B.
What is SLS's latest revenue?
Latest reported SLS revenue for 2023-12-31 was $0.
What is SLS's net income?
Net income was -$37.3M for Sellas Life Sciences Group Inc (SLS).
How did SLS revenue change on this page?
Revenue was down 100.0% from 2022-12-31 to 2023-12-31.
How many SLS vs SLV comparison scalars are listed on this page?
This page lists 4 cached comparison scalars for SLS vs SLV: SLS market cap, SLS revenue, SLS net income, and SLS revenue change.
Where is the SLS vs SLV comparison listed?
The cached SLS vs SLV comparison is listed at https://lician.com/compare/sls-vs-slv.
Not investment advice.